非肥胖与肥胖妊娠期糖尿病女性的代谢组学特征
研究比较非肥胖(BMI<30)与肥胖(BMI≥30)妊娠期糖尿病(GDM)女性和肥胖非GDM女性与非肥胖非GDM对照的代谢组学差异。在755名孕妇中于孕早、中、晚期检测66项代谢指标,并在490名孕妇中独立重复。三组GDM/肥胖女性在13项指标上相似地偏离对照,部分指标差异在肥胖GDM中更明显,多数差异在孕早期即出现,重复队列中同向差异多于随机预期。
要点
- 非肥胖与肥胖GDM及肥胖非GDM女性在13项代谢指标上相似地偏离对照。
- 6项指标(脂肪酸比值、糖酵解相关指标、缬氨酸、3-羟基丁酸)在肥胖GDM与对照间差异更明显。
- 16项指标(HDL相关、脂肪酸比值、氨基酸、炎症)在肥胖GDM或肥胖非GDM与对照间差异更明显。
核心结论
- 非肥胖与肥胖GDM女性或肥胖非GDM女性与对照间的代谢组学差异,可能有助于识别高风险女性以及时进行针对性预防干预。
研究设计与样本
- 在PREDO和RADIEL研究的755名孕妇中,于孕早期(中位13周,IQR 12.4-13.7)、孕中期(20周,19.3-23.0)和孕晚期(28周,27.0-35.0)采血检测66项代谢指标。
- 独立重复队列包括490名孕妇。
主要发现
- 非肥胖GDM、肥胖GDM和肥胖非GDM女性在孕早、中、晚期均有13项指标(包括极低密度脂蛋白相关指标和脂肪酸)与对照存在相似差异。
- 在6项指标(包括脂肪酸比值、糖酵解相关指标、缬氨酸和3-羟基丁酸)上,肥胖GDM女性与对照的差异比非肥胖GDM或肥胖非GDM女性与对照的差异更明显。
- 在16项指标(包括HDL相关指标、脂肪酸比值、氨基酸和炎症)上,肥胖GDM或肥胖非GDM女性与对照的差异比非肥胖GDM女性与对照的差异更明显。
- 多数差异在孕早期即已显现,在重复队列中同向差异出现的频率高于随机预期。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: In non-pregnant population, nonobese individuals with obesity-related metabolome have increased risk for type 2 diabetes and cardiovascular diseases. The risk of these diseases is also increased after gestational diabetes. OBJECTIVE: This work aimed to examine whether nonobese (body mass index [BMI] < 30) and obese (BMI ≥ 30) women with gestational diabetes mellitus (GDM) and obese non-GDM women differ in metabolomic profiles from nonobese non-GDM controls. METHODS: Levels of 66 metabolic measures were assessed in early (median 13, IQR 12.4-13.7 gestation weeks), and across early, mid (20, 19.3-23.0), and late (28, 27.0-35.0) pregnancy blood samples in 755 pregnant women from the PREDO and RADIEL studies. The independent replication cohort comprised 490 pregnant women. RESULTS: Nonobese and obese GDM, and obese non-GDM women differed similarly from the controls across early, mid, and late pregnancy in 13 measures, including very low-density lipoprotein-related measures, and fatty acids. In 6 measures, including fatty acid (FA) ratios, glycolysis-related measures, valine, and 3-hydroxybutyrate, the differences between obese GDM women and controls were more pronounced than the differences between nonobese GDM or obese non-GDM women and controls. In 16 measures, including HDL-related measures, FA ratios, amino acids, and inflammation, differences between obese GDM or obese non-GDM women and controls were more pronounced than the differences between nonobese GDM women and controls. Most differences were evident in early pregnancy, and in the replication cohort were more often in the same direction than would be expected by chance alone. CONCLUSION: Differences between nonobese and obese GDM, or obese non-GDM women and controls in metabolomic profiles may allow detection of high-risk women for timely targeted preventive interventions.
引用
- Sormunen-Harju H, Huvinen E, Girchenko PV, et al. Metabolomic Profiles of Nonobese and Obese Women With Gestational Diabetes. J Clin Endocrinol Metab. 2023. PMID: 37220084. doi:10.1210/clinem/dgad288
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。